Artiva Biotherapeutics (ARTV) Depreciation and Depletion (2023 - 2026)
Artiva Biotherapeutics' (ARTV) quarterly Depreciation and Depletion came in at $600000.0 in Q1 2026, little changed year-on-year from $600000.0 in Q1 2025, and little changed on a QoQ basis from $600000.0 in Q4 2025.
Artiva Biotherapeutics (ARTV) Depreciation and Depletion (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Depreciation and Depletion data on file, last reported at $600000.0 in Q1 2026.
- On a quarterly basis, Depreciation and Depletion changed 0.0% year-over-year to $600000.0 in Q1 2026; TTM through Mar 2026 was $2.4 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $2.5 million, up 4.17% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $600000.0, roughly flat from $600000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for ARTV reached as high as $600000.0 in Q3 2023 and fell as low as $500000.0 in Q2 2023.
- Historically, Depreciation and Depletion has averaged $591666.7 across 4 years, with a median of $600000.0 in 2023.
- On a YoY basis, Depreciation and Depletion climbed as much as 20.0% in 2024 and fell as far as 0.0% in 2024.
- Year by year, Depreciation and Depletion stood at $600000.0 in 2023, then changed by 0.0% to $600000.0 in 2024, then changed by 0.0% to $600000.0 in 2025, then changed by 0.0% to $600000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $600000.0 in Q1 2026, $600000.0 in Q4 2025, and $600000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | - |
| 10 | Artiva Biotherapeutics | 249.99 Mn | 249.99 Mn | - | 600,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 600,000.00 |
| Mar 31, 2026 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Sep 30, 2025 | 600,000.00 |
| Sep 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 600,000.00 |
| Dec 31, 2024 | 600,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Dec 31, 2023 | 600,000.00 |
| Dec 31, 2023 | 600,000.00 |